Company intelligence / Profile preview

Purbeck BioPharma Associates, LLC

Ownership: Private
Development stage: Preclinical

Overview

Purbeck BioPharma Associates, LLC provides a portfolio of enterprise-grade omnichannel products through its operating system called "the Omnichannel." There is no mention of drug discovery, clinical trials, or therapeutic assets; the company appears to offer technology solutions rather than develop pharmaceuticals directly[1].

Industry: Biomedical IT and Biomedical Data Platforms

Drug pipeline

1 asset

110766

Pre-clinical

Indications: PEDV infection

Beyond the preview

Go deeper on Purbeck BioPharma Associates, LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purbeck BioPharma Associates, LLC.

Explore the full profile